SecSonar.com

Vaxart, Inc. (VXRT)

Vaxart, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Vaxart, Inc. (VXRT) is a Biotechnology company based in US with a market capitalization of $159.3M. Revenue grew 726.7% year-over-year and the company generated $7.6M in free cash flow. This page tracks VXRT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 105 employees · IPO Dec 11, 1981

Valuation

Valuation & price

$0.68 · as of May 17, 2026 · -15.0% vs 52w high

9.6

P/E ratio

Latest-FY diluted EPS

1.81

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$0.80$0.55$0.30Jul 25Dec 25Jul 26Jul 7, 25$0.32Jul 9, 25$0.30Jul 11, 25$0.45Jul 15, 25$0.37Jul 17, 25$0.40Jul 21, 25$0.42Jul 23, 25$0.42Jul 25, 25$0.40Jul 29, 25$0.40Jul 31, 25$0.37Aug 4, 25$0.37Aug 6, 25$0.40Aug 11, 25$0.37Aug 13, 25$0.37Aug 15, 25$0.37Aug 19, 25$0.37Aug 21, 25$0.36Aug 25, 25$0.35Aug 27, 25$0.37Aug 29, 25$0.39Sep 3, 25$0.39Sep 5, 25$0.38Sep 9, 25$0.38Sep 11, 25$0.39Sep 16, 25$0.39Sep 18, 25$0.39Sep 22, 25$0.38Sep 24, 25$0.37Sep 26, 25$0.37Sep 30, 25$0.36Oct 2, 25$0.37Oct 6, 25$0.36Oct 8, 25$0.34Oct 10, 25$0.35Oct 14, 25$0.34Oct 16, 25$0.36Oct 21, 25$0.36Oct 23, 25$0.36Oct 27, 25$0.36Oct 29, 25$0.35Oct 31, 25$0.33Nov 4, 25$0.34Nov 6, 25$0.38Nov 10, 25$0.40Nov 12, 25$0.36Nov 14, 25$0.41Nov 18, 25$0.39Nov 20, 25$0.38Nov 25, 25$0.35Nov 28, 25$0.37Dec 2, 25$0.38Dec 4, 25$0.37Dec 8, 25$0.37Dec 10, 25$0.36Dec 12, 25$0.37Dec 16, 25$0.37Dec 18, 25$0.37Dec 22, 25$0.36Dec 24, 25$0.36Dec 29, 25$0.35Jan 2, 26$0.36Jan 6, 26$0.39Jan 8, 26$0.48Jan 12, 26$0.80Jan 14, 26$0.55Jan 16, 26$0.70Jan 21, 26$0.66Jan 23, 26$0.67Jan 27, 26$0.65Jan 29, 26$0.61Feb 2, 26$0.61Feb 4, 26$0.63Feb 9, 26$0.61Feb 11, 26$0.57Feb 13, 26$0.57Feb 18, 26$0.55Feb 20, 26$0.59Feb 24, 26$0.73Feb 26, 26$0.75Mar 2, 26$0.78Mar 4, 26$0.76Mar 6, 26$0.74Mar 10, 26$0.77Mar 12, 26$0.74Mar 17, 26$0.68Mar 19, 26$0.65Mar 23, 26$0.72Mar 25, 26$0.68Mar 27, 26$0.65Mar 31, 26$0.61Apr 2, 26$0.61Apr 7, 26$0.62Apr 9, 26$0.63Apr 13, 26$0.70Apr 15, 26$0.73Apr 17, 26$0.75Apr 22, 26$0.74Apr 24, 26$0.72Apr 28, 26$0.76Apr 30, 26$0.77May 4, 26$0.76May 6, 26$0.74May 8, 26$0.70May 12, 26$0.68May 14, 26$0.65May 18, 26$0.63May 20, 26$0.61May 22, 26$0.64May 28, 26$0.66Jun 1, 26$0.63Jun 3, 26$0.60Jun 5, 26$0.62Jun 9, 26$0.58Jun 11, 26$0.57Jun 15, 26$0.58Jun 17, 26$0.57Jun 22, 26$0.54Jun 24, 26$0.52Jun 26, 26$0.54Jul 2, 26$0.64
$0.3052-week range$0.80
Loading valuation history…

Fundamentals

Key fundamentals

$159.3M

Market cap

726.7%

Revenue growth (YoY)

100.0%

Gross margin

$7.6M

Free cash flow (USD)

-$54.8M

Net debt

Net cash position

-52.7%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$8.9MFY 2018$4.2MFY 2019$9.9MFY 2020$4.0MFY 2021$892.0KFY 2022$107.0KFY 2023$7.4MFY 2024$28.7MFY 2025$237.3M
$8.9M$237.3M

Free cash flow by year

2017 → 2025

FY 2017$-30.5MFY 2018$-15.3MFY 2019$-13.9MFY 2020$-25.0MFY 2021$-65.0MFY 2022$-104.4MFY 2023$-72.3MFY 2024$-45.3MFY 2025$7.6M
-$30.5M$7.6M

Gross margin by year

2021 → 2025

FY 2021-5365.1%FY 2022100.0%FY 202339.0%FY 2024100.0%FY 2025100.0%
-5365.1%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventCooperation AgreementJul 2, 2026Filing
  • 8-K eventFunding ModificationJun 26, 2026Filing
  • 8-K eventPreliminary Proxy Statement FiledMay 19, 2026Filing
  • 8-K eventBusiness Update and Financial ResultsMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • Annual report10-K FiledApr 30, 2026Filing
  • 8-K eventDirector AppointmentApr 23, 2026Filing
  • 8-K eventLease AmendmentApr 21, 2026Filing
  • 8-K eventStock Purchase AgreementApr 17, 2026Filing
  • FinancingSecurities RegistrationApr 16, 2026Filing

Questions

Frequently asked questions

What is Vaxart, Inc.'s market cap?

Vaxart, Inc. (VXRT) has a market capitalization of $159.3M.

What is VXRT's P/E ratio?

VXRT trades at a price-to-earnings ratio of 9.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is VXRT's price-to-book (P/B) ratio?

VXRT trades at 1.81 times book value per share.

Are insiders buying VXRT stock?

SEC Form 4 filings show no open-market insider buys at Vaxart, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

UNCY

Unicycive Therapeutics, Inc.

$158.6M

MDWD

MediWound Ltd.

$157.8M

ORMP

Oramed Pharmaceuticals Inc.

$162.9M

SPRO

Spero Therapeutics, Inc.

$163.3M

ADAG

Adagene Inc.

$152.5M

IVVD

Invivyd, Inc.

$151.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.